Histological assessment of β-amyloid precursor protein immunolabelled rectal biopsies aids diagnosis of equine grass sickness.

The research article presents a new way to diagnose equine grass sickness (EGS) in horses using histological examination of rectal biopsies that have been immunolabeled for β-amyloid precursor protein (β-APP). The study shows this method to be more effective than traditional approaches.

Introduction

• The article discusses the problem of diagnosing equine grass sickness (EGS), a debilitating disease in horses with no accurate diagnostic measures available currently.
• The paper proposes an alternative diagnostic method; using histological examination of rectal biopsies, immunolabelled for β-amyloid precursor protein (β-APP).
• β-APP is noted to have increased expression in cranial cervical ganglia (CCG), a characteristic of EGS.
• The researchers’ objective was to develop a grading scheme assessing levels of β-APP within the rectal submucosal neurons and determine the validity of this approach in correctly diagnosing EGS.

Methods

• The study follows a retrospective case-control diagnostic accuracy style.
• A grading scheme was developed where β-APP immunoreactivity was compared in neuronal perikarya and axons in sections of CCG and ileum from EGS and control horses.
• The grading scheme was refined and blindly used on rectal biopsies from 21 EGS patients and 23 controls.

Results

• The results reveal that β-APP immunoreactivity increased in the neuronal perikarya and axons in sections of CCG, ileum, and rectum from EGS horses compared to the control group.
• For rectal biopsies, it was found that average immunoreactivity grade above 1.1 was 100% specific and sensitive to EGS.
• The presence of at least one neuron with diffuse labeling of the entire cytoplasm (grade 3) had a 95% sensitivity and 100% specificity for EGS.

Conclusion

• The results of the study suggest the effectiveness of the proposed β-APP immunolabelling as a diagnostic tool for EGS, better than traditional histological examination.
• However, the researchers underscore that a larger sample size is required to further validate the method before this technique can be recommended for use in clinical decision-making processes.